https://ir.beonemedicines.com/news/European-Commission-Approves-TEVIMBRA®-as-Neoadjuvant/Adjuvant-NSCLC-Treatment-Ahead-of-Late-Breaking-Data-Presentation-at-WCLC-2025/0d7553af-93d0-4616-a02b-ac223e497bca